InvestorsHub Logo
Followers 6
Posts 1257
Boards Moderated 0
Alias Born 06/14/2009

Re: None

Saturday, 03/19/2022 11:14:14 AM

Saturday, March 19, 2022 11:14:14 AM

Post# of 3683
Recapping last week .. CEO Purchased 132,800 @.77 .. BUY rating @$7.00
CEO pointed out the opportunity on hand after carefully studying the potential REWARDS and it OUTWEIGHS the RISK him leaving a 23 Billion dollar company. He met with every BOARD MEMBER / DIRECTORS ETC ask ALLLL ??????? about the opportunities and challenges facing the company. Commercialization is a TOP Priority and he also reviewed all preclinical and clinical studies, especially MASTERS-1 in detail to the point that he took time to speak to several physicians who treat stroke and acute respiratory distress syndrome. He also spoke to several consultants regarding cell therapy space to better understand the manufacturing and regulatory challenges facing ahead in the industry. Dan did PLENTY due diligence before he CONFIRMED his INTEREST as the NEW CEO and LEADER in place. IMAGINE someone LEAVING a BILLION DOLLAR COMPANY and ACCEPTING a JOB at Athersys and the challenges ahead. Going forward with the technical / executive teams which includes several NEW members with further support commercialization plans with Healios. THE BEST IS YET TO COME ... GOOD LUCK LONGS